As of 2025-07-15, the Fair Value of Design Therapeutics Inc (DSGN) is -5.02 USD. This value is based on the Peter Lynch's Fair Value formula. With the current market price of 4.00 USD, the upside of Design Therapeutics Inc is -225.51%.
With the market price of 4.00 USD and our fair value calculation, Design Therapeutics Inc (DSGN) is not a good investment. Investing in DSGN stocks now will result in a potential loss of 225.51%.
Note: valuation result may not be accurate due to the company's negative EPS.
Peter Lynch's formula is:
The earnings growth rate we use in the formula is the average growth rate of net income/earnings over the last 5 years. If the average growth rate is smaller than 5%, we set it to 5%. If it is larger than 25%, we set it to 25%. If the TTM EPS is negative, Peter Lynch Fair Value's result can be unreliable.
| Historical Earnings | ||||||
| 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | 5Y Avg | |
| Net income | -8.28 | -35.53 | -63.31 | -67.00 | -50.00 | -44.82 |
| YoY growth | -303.90% | -329.11% | -78.19% | -5.83% | 25.37% | -138.33% |
| Market Cap (mil) | 227.08 |
| P/E | |
| Forward P/E |
| EPS | -1.00 |
| Avg earnings growth rate | -138.33% |
| TTM earnings | -57.00 |